$0.80
+0.04 (+5.30%)
Open$0.80
Previous Close$0.76
Day High$0.80
Day Low$0.76
52W High$3.31
52W Low$0.72
Volume—
Avg Volume340.6K
Market Cap56.74M
P/E Ratio—
EPS$-0.59
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+1,259.2% upside
Current
$0.80
$0.80
Target
$10.81
$10.81
$7.63
$10.81 avg
$13.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 634.9K | 552.2K | 16.05M |
| Net Income | -48,940,375 | -38,304,493 | -3,462,613 |
| Profit Margin | -7,732.0% | -7,345.4% | -21.6% |
| EBITDA | -51,865,382 | -42,849,041 | -3,307,317 |
| Free Cash Flow | — | — | -2,137,974 |
| Rev Growth | +15.0% | +15.0% | +0.8% |
| Debt/Equity | — | — | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |